The report provides a detailed analysis essential for establishing a Fondaparinux Sodium production plant. It encompasses all critical aspects necessary for Fondaparinux Sodium production, including the cost of Fondaparinux Sodium production, Fondaparinux Sodium plant cost, Fondaparinux Sodium production costs, and the overall Fondaparinux Sodium production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Fondaparinux Sodium production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Fondaparinux Sodium is a synthetic anticoagulant that plays an important role in medical settings where preventing blood clots is essential. It is widely used to treat and prevent deep vein thrombosis and pulmonary embolism, particularly after major surgeries such as hip or knee replacement.
It also finds its application as a medication in patients with acute coronary syndromes to reduce the risk of clot-related complications. It is often used when patients cannot take other anticoagulants or need a more predictable response. In addition to its clinical use, Fondaparinux Sodium is also used in research to study blood-clotting mechanisms and evaluate new therapies designed to manage or prevent thrombotic disorders.
The demand for Fondaparinux Sodium is predominantly driven by its application as an anticoagulant in healthcare to prevent and manage blood clots, which contributes to its market expansion. Its application as a dependable anticoagulant in patients undergoing major surgeries or dealing with deep vein thrombosis and pulmonary embolism also boosts its demand in the medical and pharmaceutical industries. The increasing need for safer blood-thinning options like Fondaparinux Sodium, due to its predictable action and suitability for patients who cannot use other anticoagulants, also promotes its market growth. Its role in managing acute coronary syndromes further contributes to its growing demand in the medical sector.
Additionally, industrial Fondaparinux Sodium procurement is influenced by factors such as the availability and cost of key raw materials, adherence to strict regulatory standards, and compliance with safety and quality guidelines. Advancements in synthetic chemistry, improved production efficiency, and dependable supply chain networks also play a major role in shaping its global procurement. Furthermore, ongoing research into safer and more effective anticoagulant therapies also boosts demand for Fondaparinux Sodium in clinical practice.
Raw Material for Fondaparinux Sodium Production
According to the Fondaparinux Sodium production plant project report, the major raw materials for Fondaparinux Sodium production includes D-glucose/ D-cellobiose/ D-glucosamine.
Manufacturing Process of Fondaparinux Sodium
The extensive Fondaparinux Sodium production cost report consists of the following industrial production processes:
- Production from Simple Sugars: The production process of Fondaparinux Sodium begins with the conversion of simple sugars, such as D-glucose, D-cellobiose, and D-glucosamine, into the required monosaccharide building blocks. These building blocks are then protected and selectively modified through a long multistep sequence. These protected units are assembled into two key fragments, including a trisaccharide and a disaccharide, which serve as the core building blocks for the final pentasaccharide. The trisaccharide is prepared through selective protection, epoxide formation, azide introduction, and a controlled glycosylation step, while the disaccharide is produced by selective acetylation and coupling under mild conditions. Once both fragments are ready, they are joined at low temperature to form a fully protected pentasaccharide. Further, this intermediate is converted into the active compound by removing protecting groups, followed by O-sulfation and N-sulfation, and final purification steps to obtain Fondaparinux Sodium as the product.
Fondaparinux sodium is a synthetic anticoagulant that exists in the form of a white to off-white powder. Its molecular formula is C31H43N3Na10O49S8 and its molar mass is about 1728.08 g/mol. It dissolves readily in water, as it is a decasodium salt of a sulfated pentasaccharide. The compound decomposes upon heating (melting-point > 209 degree Celsius) rather than flowing like a simple molecular solid. It is the decasodium salt of a complex sulfated pentasaccharide and is commercially used in the form of a stable solid (white/off-white) under controlled storage. It is administered in aqueous solution for anticoagulant therapy.
